Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Southwest Airlines reports third-quarter results on October 21 with the stock down 5% on the week, carrying a notable activist overhang and a potential index exit that adds mechanical selling pressure beyond the earnings itself.
The most consequential ownership story is Elliott Investment Management, which remains on the Schedule 13D register as an activist filer. Elliott's disclosed stake has fallen from 9.3% to 4.9% as of its last filing in April, but because the position sits just below the 5% threshold, any further reduction may never trigger a fresh disclosure. The presence of a 13D filer, even a retreating one, signals that the board has been, and may still be, under pressure. Alongside Elliott, PRIMECAP and Franklin Templeton have both crossed the 10% ownership mark in recent filings, providing a counterweight of longer-term conviction holders. Schedule 13D/G positions are event-driven disclosures around the 5% threshold; stakes are as last disclosed, and holders dropping below 5% may exit without a further filing.
Options positioning has turned more defensive into the print, though not alarmingly so. The put/call ratio is running at 0.85, above its 20-day average of 0.79 and about 1.2 standard deviations elevated, a directional lean toward hedging rather than a crowded fear trade. The lending market tells a much calmer story: availability is exceptionally loose at over 2,100%, meaning there are roughly 21 shares available to borrow for every one currently lent out, and borrowing costs remain negligible at 0.42%. Short interest at 4.5% of the free float is not particularly high, though it has risen about 7% over the past week, suggesting some traders have added bearish positions into the release. That build is modest in the context of the broader retreat from the 30%-plus short positions seen in September.
The analyst community remains broadly constructive but has been consistently cutting targets. UBS trimmed its target to $52 on October 16, one day before this report, while maintaining a Buy. TD Cowen, BMO and Barclays have all reduced targets over the past month, in some cases by $7 to $10. The mean target has settled around $49, implying roughly 24% upside from Friday's $39.50 close. Bears point to execution risk around the ongoing assigned seating rollout and pressure on close-in leisure fares. Bulls argue the basic economy product launched in mid-2025 lifts load factors without cannibalising higher-yield revenue, and that the aircraft monetisation programme provides a financial cushion. EPS momentum factor scores rank in the bottom quartile over both 30-day and 90-day windows, suggesting the Street's forward estimates have been drifting lower rather than building.
There is also an index angle that sits in the background. ORTEX puts the probability at 60% that LUV is deleted from both the CRSP US Large and CRSP US Mid indices at the December 2026 quarterly review, with the stock currently trading about 5.6% below the price that would flip the call. That price is $43.13. The combined passive selling flow attached to both deletions is estimated at roughly $251 million. The rank date for the review is December 4, so the earnings print and the trajectory of the stock into year-end will determine whether that mechanical selling pressure materialises at all.
The sector is broadly weaker: peers DAL and UAL are down 8% and 11% respectively on the week, and ULCC and JBLU have fallen harder still. Southwest's relative resilience on the weekly move, down only 5%, is not necessarily a positive signal given that the group is in a broad downdraft. The October 21 print will test whether the airline's turnaround metrics, yield trends and seating transition costs are tracking well enough to justify the Street's buy-side tilt in an environment where the sector is already under pressure.
See the live data behind this article on ORTEX.
Open LUV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.